Author: Borman R.
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.6, Iss.1, 2001-04, pp. : 57-68
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. :
Quality of Life in Irritable Bowel Syndrome
PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. :